Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019

Published : May-2019

No. of Pages : 555

order by fax Inquire before Buying request discount

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Transdermal Drug Delivery Devices Overview
3 Products under Development
3.1 Transdermal Drug Delivery Devices - Pipeline Products by Stage of Development
3.2 Transdermal Drug Delivery Devices - Pipeline Products by Segment
3.3 Transdermal Drug Delivery Devices - Pipeline Products by Territory
3.4 Transdermal Drug Delivery Devices - Pipeline Products by Regulatory Path
3.5 Transdermal Drug Delivery Devices - Pipeline Products by Estimated Approval Date
3.6 Transdermal Drug Delivery Devices - Ongoing Clinical Trials
4 Transdermal Drug Delivery Devices - Pipeline Products under Development by Companies
4.1 Transdermal Drug Delivery Devices Companies - Pipeline Products by Stage of Development
4.2 Transdermal Drug Delivery Devices - Pipeline Products by Stage of Development
5 Transdermal Drug Delivery Devices Companies and Product Overview
5.1 3M Co Company Overview
5.2 4P Therapeutics LLC Company Overview
5.3 Actuated Medical Inc Company Overview
5.4 Aequus Pharmaceuticals Inc Company Overview
5.5 Agile Therapeutics Inc Company Overview
5.6 Allergan Plc Company Overview
5.7 Alliqua BioMedical Inc Company Overview
5.8 AMW GmbH Company Overview
5.9 AngioSoma Inc Company Overview
5.10 Apogee Technology Inc Company Overview
5.11 Asahi Kasei Pharma Corp Company Overview
5.12 AstraZeneca Plc Company Overview
5.13 Avro Life Sciences Company Overview
5.14 Boryung Pharmaceutical Co Ltd Company Overview
5.15 Burke Pharmaceuticals LLC Company Overview
5.16 Cassava Sciences Inc Company Overview
5.17 CB Scientific Inc Company Overview
5.18 Cerimon Pharmaceuticals, Inc. (Inactive) Company Overview
5.19 ChemioCare USA Inc Company Overview
5.20 Chrono Therapeutics Inc Company Overview
5.21 Cipla Ltd Company Overview
5.22 Clexio Biosciences Ltd Company Overview
5.23 Corium International Inc Company Overview
5.24 Daewoong Pharmaceutical Co Ltd Company Overview
5.25 DBV Technologies SA Company Overview
5.26 DD Therapeutics LLC Company Overview
5.27 Dermisonics Inc (Inactive) Company Overview
5.28 Dharma Therapeutics, Inc. (Inactive) Company Overview
5.29 Drexel University Company Overview
5.30 DURECT Corp Company Overview
5.31 Echo Therapeutics Inc Company Overview
5.32 Emplicure AB Company Overview
5.33 Endo International Plc Company Overview
5.34 Extend Biosciences Inc Company Overview
5.35 Fe3 Medical Inc Company Overview
5.36 Georgia Institute of Technology Company Overview
5.37 Georgia State University Company Overview
5.38 Hisamitsu Pharmaceutical Co Inc Company Overview
5.39 I.M. Sechenov Moscow State Medical University Company Overview
5.40 Icure Pharmaceutical Inc Company Overview
5.41 ImmuPatch Company Overview
5.42 Indian Institute of Science Company Overview
5.43 Indian Institute of Technology Bombay Company Overview
5.44 InMed Pharmaceuticals Inc Company Overview
5.45 Institute of Materials Research & Engineering Company Overview
5.46 Intercell AG (Inactive) Company Overview
5.47 Interstitial NS Company Overview
5.48 Isis Biopolymer Inc (Inactive) Company Overview
5.49 Janisys Company Overview
5.50 KTH Royal Institute of Technology Company Overview
5.51 LEO Pharma A/S Company Overview
5.52 Lohmann Therapie-Systeme AG Company Overview
5.53 Luye Pharma Group Ltd Company Overview
5.54 Massachusetts Institute of Technology Company Overview
5.55 Mayne Pharma Group Ltd Company Overview
5.56 Medherant Ltd Company Overview
5.57 Medifron DBT Inc Company Overview
5.58 MEDRx Co Ltd Company Overview
5.59 MedRx, Inc. Company Overview
5.60 Microdermics Inc Company Overview
5.61 Micron Biomedical Inc Company Overview
5.62 Micropoint Technologies Pte Ltd Company Overview
5.63 National University of Singapore Company Overview
5.64 Nemaura Pharma Ltd Company Overview
5.65 NeuroDerm Ltd Company Overview
5.66 Nitto Denko Corp Company Overview
5.67 North Carolina State University Company Overview
5.68 Noven Pharmaceuticals Inc Company Overview
5.69 NutriBand Inc Company Overview
5.70 Nuvo Pharmaceuticals Inc Company Overview
5.71 Phosphagenics Ltd Company Overview
5.72 Prometheon Pharma LLC Company Overview
5.73 Purdue University Company Overview
5.74 Radius Health Inc Company Overview
5.75 Scilex Ltd Company Overview
5.76 Seelos Therapeutics Inc Company Overview
5.77 Shenox Pharmaceuticals LLC Company Overview
5.78 Sinsin Pharmaceutical Co Ltd Company Overview
5.79 Skinject Inc Company Overview
5.80 Sparsha Pharma International Pvt Ltd Company Overview
5.81 Sparsha Pharma USA Inc Company Overview
5.82 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
5.83 Stanford University Company Overview
5.84 Sumitomo Dainippon Pharma Co Ltd Company Overview
5.85 Syntropharma Ltd Company Overview
5.86 Taho Pharmaceuticals Ltd Company Overview
5.87 Teikoku Pharma USA Inc Company Overview
5.88 tesa Labtec GmbH Company Overview
5.89 Teva Pharmaceutical Industries Ltd Company Overview
5.90 The Sheikh Zayed Institute for Pediatric Surgical Innovation Company Overview
5.91 TheraJect Inc Company Overview
5.92 Therapeutic Systems Research Laboratories Inc Company Overview
5.93 TheraSolve NV Company Overview
5.94 Theratech, Inc. Company Overview
5.95 Thrudermic LLC Company Overview
5.96 Titan Pharmaceuticals Inc Company Overview
5.97 Toa Eiyo Ltd Company Overview
5.98 Transcu Group Limited (Inactive) Company Overview
5.99 Transdermal Delivery Solutions Corp Company Overview
5.100 Transdermal Specialties Inc Company Overview
5.101 TransPharma Medical Ltd (Inactive) Company Overview
5.102 Transport Pharmaceuticals Inc Company Overview
5.103 Univec, Inc. (Inactive) Company Overview
5.104 University of Illinois at Chicago Company Overview
5.105 University of North Carolina at Chapel Hill School of Medicine Company Overview
5.106 University of Toronto Company Overview
5.107 ViiV Healthcare UK Ltd Company Overview
5.108 Vyteris, Inc. (Inactive) Company Overview
5.109 Xel Pharmaceuticals Inc Company Overview
5.110 Zambon Italia Srl Company Overview
5.111 Z-Cube Srl Company Overview
5.112 ZetrOZ, Inc. Company Overview
5.113 Zosano Pharma Corp Company Overview
5.114 Zynerba Pharmaceuticals Inc Company Overview
6 Transdermal Drug Delivery Devices - Recent Developments
6.1 Apr 29, 2019: ChemioCare announces appointment of Roy F. Waldron to its board of directors
6.2 Apr 25, 2019: 3M reports first-quarter 2019 results; company initiates restructuring
6.3 Apr 25, 2019: The Medicines Company reports first-quarter 2019 financial results and significant progress with the Inclisiran clinical development program
6.4 Apr 25, 2019: DURECT appoints two new board members
6.5 Apr 22, 2019: KalVista Pharmaceuticals names Daniel B. Soland to board of directors
6.6 Apr 19, 2019: Alvogen issues voluntary nationwide recall of Fentanyl Transdermal System due to product mislabeling
6.7 Apr 11, 2019: Sumitomo Dainippon Pharma announces mid-term business plan 2022
6.8 Apr 10, 2019: Teva signs new $2.3 billion syndicated revolving credit facility
6.9 Apr 09, 2019: Revance appoints former Allergan marketing veteran Taryn Conway as Vice President of marketing
6.10 Apr 08, 2019: Generex Biotechnology appoints Mark J. Prioletti to the board of directors
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

1.1 List of Tables
Table 1: Transdermal Drug Delivery Devices - Pipeline Products by Stage of Development
Table 2: Transdermal Drug Delivery Devices - Pipeline Products by Segment
Table 3: Transdermal Drug Delivery Devices - Pipeline Products by Territory
Table 4: Transdermal Drug Delivery Devices - Pipeline Products by Regulatory Path
Table 5: Transdermal Drug Delivery Devices - Pipeline Products by Estimated Approval Date
Table 6: Transdermal Drug Delivery Devices - Ongoing Clinical Trials
Table 7: Transdermal Drug Delivery Devices Companies - Pipeline Products by Stage of Development
Table 8: Transdermal Drug Delivery Devices - Pipeline Products by Stage of Development
Table 9: 3M Co Pipeline Products & Ongoing Clinical Trials Overview
Table 10: 3M Hollow Microstructured Transdermal System - Product Status
Table 11: 3M Hollow Microstructured Transdermal System - Product Description
Table 12: 4P Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 13: 4P Clonidine Transdermal Patch - Product Status
Table 14: 4P Clonidine Transdermal Patch - Product Description
Table 15: 4P Scopolamine Transdermal Patch - Product Status
Table 16: 4P Scopolamine Transdermal Patch - Product Description
Table 17: Defent - Product Status
Table 18: Defent - Product Description
Table 19: Passive Transdermal Lidocaine Patch - Product Status
Table 20: Passive Transdermal Lidocaine Patch - Product Description
Table 21: Passive Transdermal Patch - Product Status
Table 22: Passive Transdermal Patch - Product Description
Table 23: Transdermal Apomorphine Patch - Product Status
Table 24: Transdermal Apomorphine Patch - Product Description
Table 25: Transdermal Exenatide Patch - Product Status
Table 26: Transdermal Exenatide Patch - Product Description
Table 27: Transdermal FSH Patch - Product Status
Table 28: Transdermal FSH Patch - Product Description
Table 29: Transdermal Patch - Diabetes - Product Status
Table 30: Transdermal Patch - Diabetes - Product Description
Table 31: Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 32: GentleDispense System - Product Status
Table 33: GentleDispense System - Product Description
Table 34: Aequus Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 35: AQS1301 - Product Status
Table 36: AQS1301 - Product Description
Table 37: AQS1302 - Product Status
Table 38: AQS1302 - Product Description
Table 39: AQS1303 - Product Status
Table 40: AQS1303 - Product Description
Table 41: AQS1304 - Product Status
Table 42: AQS1304 - Product Description
Table 43: Aequus Pharmaceuticals Inc - Ongoing Clinical Trials Overview
Table 44: AQS1301 - Phase Ia Study of AQS-1301 in Healthy Subjects
Table 45: Agile Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 46: AG200-ER Patch - Product Status
Table 47: AG200-ER Patch - Product Description
Table 48: AG200-SP Patch - Product Status
Table 49: AG200-SP Patch - Product Description
Table 50: AG890 Patch - Product Status
Table 51: AG890 Patch - Product Description
Table 52: Twirla (AG200-15) - Product Status
Table 53: Twirla (AG200-15) - Product Description
Table 54: Agile Therapeutics Inc - Ongoing Clinical Trials Overview
Table 55: Twirla (AG200-15) - Assessing Adhesion with Transdermal and Topical Delivery Systems for ANDAs
Table 56: Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 57: Nanotechnology-Based Transdermal Delivery System - Product Status
Table 58: Nanotechnology-Based Transdermal Delivery System - Product Description
Table 59: Norethindrone Transdermal Delivery System - Product Status
Table 60: Norethindrone Transdermal Delivery System - Product Description

1.2 List of Figures
Figure 1: Transdermal Drug Delivery Devices - Pipeline Products by Stage of Development
Figure 2: Transdermal Drug Delivery Devices - Pipeline Products by Segment
Figure 3: Transdermal Drug Delivery Devices - Pipeline Products by Territory
Figure 4: Transdermal Drug Delivery Devices - Pipeline Products by Regulatory Path
Figure 5: Transdermal Drug Delivery Devices - Pipeline Products by Estimated Approval Date
Figure 6: Transdermal Drug Delivery Devices - Ongoing Clinical Trials

Filed in: Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027 “Increased cases of traumatic injuries and increasing surgical procedures worldwide are driving the overall growth of the wound care market” The global wound care market is projected to reach USD 27.2 billion by 2027 from USD 20.8 billion in 2022, at a CAGR of 5.4% during the forecast period. Market growth is driven by factors such as increase in traumatic injuries, increased in number of surgical wounds and increased spending on traumatic wound management. On the other hand, challenges associated with wound care product validation and shortage of skilled professionals are the major factors hampering the growth of this market. “The advanced wound care products segment accounted for the highest growth rate in the wound care market, by product, during the forecast period” T......	$8150
Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027 “The rehabilitation equipment market is projected to grow at a CAGR of 5.9% between 2022 and 2027.” The global rehabilitation equipment market is projected to reach USD 19.8 billion by 2027 from USD 14.9 billion in 2022, at a CAGR of 5.9% during the forecast period. Increasing geriatric population and obese populations, increasing chronic diseases, high risk of injuries to caregivers during the manual handling of patients, and increasing demand for rehabilitation care, owing to an increasing access to healthcare are the key driving factors in the market. However, a lack of awareness and access to rehabilitation services in emerging countries is a major factor restraining market growth. “Therapy equipment was the largest and fastest-growing segment in the product segment of reha......	$4950
Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027 "Increasing sports injuries and active participation are driving the overall growth of the cold pain therapy market." The global cold pain therapy market is projected to reach USD 2.4 billion by 2027 from USD 1.8 billion in 2022, at a CAGR of 5.1% during the forecast period. Growth in this market is mainly driven by growing incidence of arthritis and availability of cold pain products at affordable cost. "The OTC products segment accounted for the highest growth rate in the cold pain therapy market, by product, during the forecast period." The cold pain therapy market is segmented into OTC products and prescription products based on product. In 2021, the OTC products segment accounted for the highest growth rate in the cold pain therapy market. Market growth can largely be attri......	$4950
Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027 “Increasing research investments into the neurological compilations and the expanding geriatric population are pushing the growth of the nerve repair & regeneration market.” The global nerve repair & regeneration market is expected to reach USD 11.6 billion by 2027 from USD 6.5 billion in 2022, at a CAGR of 12.1%.The growth in this market is driven by increasing research expenditure on the neurological disorders by the government, the increasing R&D investments by the market players into the neuromodulation and neurostimulation devices and the biomaterials. Also, the expanding geriatric population base dries the growth of the market by placing more demand of the nerve repair and regeneration products. “The biomaterialas segment is anticipated to grow at the fastest ......	$4950
Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027 MarketsandMarkets expects particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027. Market growth is driven by factors such as the various advantages offered by the growing global prevalence of cancer, particle therapy advantages over photon therapy, increasing acceptance of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide. However, affordability & accessibility of treatments and infrastructural are expected to limit market growth to a certain extent in the coming years. In this report, the particle therapy market is segmented on the basis of type, product and services, cancer type, application, cancer type, and region. “Treatment Applicat......	$4950
Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027 “The global restorative dentistry market is projected to grow at a CAGR of 6.1%” Restorative dentistry restores mouth functions & its aesthetic state by efficiently managing oral health problems through dental restoration. Dental restoration procedures include the use of implants and prosthetics made by restorative material to restore the function, integrity, and morphology of the missing tooth or to repair the missing parts of the tooth structure resulted from dental caries or injuries. The global restorative dentistry market is projected to reach USD 22.2 billion by 2027 from USD 16.5 billion in 2022, at a CAGR of 6.1%. “The prosthetic materials segment is expected to account for the largest share of the restorative dentistry market” The prosthetic materials segment ......	$4950
Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027 “Rapid growth in the geriatric population and the associated increase in the prevalence of edentulism is expected to drive the overall growth of the dental laboratories market.” Edentulism (tooth loss) is a major oral health concern among the elderly; according to the WHO (2020), globally, ~19% of individuals aged between 65 and 74 years are edentulous. Periodontal diseases and dental cavities are the major causes of tooth loss. As the elderly are more susceptible to such ailments, the growth of this population segment will increase the number of people suffering from oral health problems globally. According to the UN, the global geriatric population (aged 65 years and above) will increase from 703 million in 2019 to 1.5 billion in 2050. Thus, significant growth in the geriatric pop......	$4950
Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027) “Endoscope reprocessing market is projected to grow at CAGR of 9.7% from 2022 to 2027” The global endoscope reprocessing market is projected to USD 3.8 billion by 2027 from USD 2.4 billion in 2022, at a CAGR of 9.7% from 2022 to 2027.The growth of this market is driven owing to increasing requirement for endoscopy to diagnose and treat target diseases, high risk of Endoscope-associated infections due to contaminated endoscopes, Growing geriatric population and leading to increase in endoscopic procedures, and Increasing emphasis on improving reprocessing guidelines by healthcare authorities. Also, Increasing investments, funds, and grants to improve healthcare infrastructure and research areas of endoscopy is anticipated to offer an opportunity for the growth of the market during th......	$4950
Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027 “Rising demand from the electronics industry and expected recovery from impact of COVID-19 and rising penetration of EVs expected to drive market.” The global Polymethyl Methacrylate (PMMA) market is projected to grow from USD 4.8 Billion in 2022 to USD 6.3 Billion by 2027, at a CAGR of 5.4% during the forecast period. Increasing usage of PMMA in construction, automotive, electronics, and other end-use industries are driving the demand for PMMA during the forecast period. However, availability of low-cost substitutes is expected to hamper market growth. PMMA is a versatile, recyclable, sustainable, and durable material, owing to which it is gaining traction across several industrial applications. Due to its superior properties and the changing government policies such as European Gr......	$4950
Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027 “The hospital laboratories is projected to grow at CAGR of 7.1% from 2022 to 2027” Based on End user the market is classified into, The hospital laboratories, clinical laboratories, and other end users . The growth of this market is majorly driven by the increasing number of specialty diagnostic tests performed in hospital laboratories, rising number of in-house clinical diagnostic procedures in hospitals, rising number of hospitals across the globe, and the growing trend of establishing in-house clinical diagnostic capabilities in hospitals. “Microtome instruments in the product segment to witness the highest shares during the forecast period.” Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibra......	$4950

Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen), Devices (NPWT, Assessment, Debridement), Graft, Matrix, Suture, Stapler), Wound(DFUs, Trauma, Surgical, Burn), End User (Hospitals, Clinics) & Region – Global Forecast to 2027

Rehabilitation Equipment Market by Product (Medical Bed, Mobility Scooter, Walker, Crutcher, Cane, Patient Lift, Sling), Application (Physical, OT, Lower-body Exercise Equipment), End User (Rehabilitation & Physiotherapy Center) – Global Forecast to 2027

Cold Pain Therapy Market by Product (OTC (Gels, Creams, Patches, Wraps, Pads), Prescription (Motorized, Non-motorized)), Application (Musculoskeletal, Post-Op, Sports Injuries), Distribution Channel (Hospital, Retail, E-Pharmacy) – Global Forecast to 2027

Nerve Repair & Regeneration Market by Products (Neuromodulation Devices (Deep Brain Stimulation, Vagus Nerve Stimulation), Biomaterials (Nerve Conduits, Nerve Wraps), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) – Global Forecast to 2027

Particle Therapy Market by Type (Proton Therapy, Heavy Ion), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate), Application (Treatment, Research) – Global Forecast to 2027

Restorative Dentistry Market by Product (Restorative Material (Glass-ionomers, Bonding Agents, Biomaterial), Implant, Prosthetic, Equipment (Handpiece, Articulator, Furnace), End User (Hospital, Clinic, Laboratory) – Global Forecast to 2027

Dental Laboratories Market by Material (Metal Ceramic, CAD/CAM Material (Zirconia, Glass Ceramic)), Equipment (Milling Equipment, CAD/CAM System, 3D Printing System, Scanner, Furnace), Prosthetics (Bridge, Crown, Veeners, Denture) – Global Forecast to 2027

Endoscope Reprocessing Market by Product (HLD and Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors (AER), Endoscope Drying, Storage, & Transport Systems, Tracking Solutions), End User (Hospitals, ASCs & Clinics) (2022 – 2027)

Polymethyl Methacrylate (PMMA) Market by Grade (General Purpose, Optical), Form(Extruded Sheet, Cast Acrylic Sheet, Pellets, Beads),End-Use Industry(Signs & Displays, Construction, Automotive, Lighting Fixtures, Electronics, Marine, Healthcare) & Region – Global Forecast to 2027

Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End User (Hospital, Clinical Labs) – Global Forecast to 2027